查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1830871

就地检验（POC​​T）全球市场报告（2025年）

Point-Of-Care-Testing (POCT) Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，就地检验（POC​​T）市场规模快速扩张，从2024年的454.5亿美元成长到2025年的507.9亿美元，复合年增长率达11.8%。这段时期的成长可归因于对个人化医疗的日益重视、医疗基础设施投资的增加、急诊病例数量的增加、照护现场分子检测的日益普及以及人工智慧在诊断领域日益广泛的应用。

预计未来几年，就地检验（POC​​T）市场将快速成长，到2029年市场规模将达到781.9亿美元，复合年增长率（CAGR）为11.4%。预测期内的成长可归因于个人化医疗需求的不断增长、远端医疗和远距监测的日益普及、新兴市场医疗保健服务可及性的提高、在非传统医疗环境中的广泛应用以及可穿戴诊断设备的日益普及。预测期内的主要趋势包括多重检测平台的演进、可携式分子诊断设备的开发、基于智慧型手机的诊断工具的创新、连接性和数据整合能力的提升以及人工智慧驱动的POCT解决方案的出现。

就地检验（POC​​T）是指在患者接受治疗的地点或附近进行的诊断检测，可提供即时结果，从而加速临床决策。其目标是在患者接受治疗的地点直接提供快速且准确的诊断讯息，以促进及时治疗并改善患者预后。

就地检验(POCT) 的主要类型包括血糖值检测、传染病检查、心臟标记检测、血液凝固检验、怀孕和不孕症检测、血液气体和电解质检测以及尿液检查。血糖值检测测量血液中的糖（葡萄糖）含量，用于监测和管理相关疾病。 POCT 产品有多种购买管道，包括非处方药和处方笺药，并采用免疫检测、分子诊断、微生物检测、聚合酵素链锁反应(PCR) 检测和生物化学检验等技术。主要终端使用者包括临床实验室、门诊医疗机构、医生诊所、药局、零售诊所、电商平台、医院、加护治疗中心、急诊中心、居家医疗、自我检测。

美国关税的快速上涨以及由此引发的贸易摩擦将持续到2025年，这对医疗设备行业产生了重大影响，尤其是进口诊断成像设备部件、手术用不銹钢和塑料耗材。医院和诊所都在抵制价格上涨，这挤压了製造商的净利率。监管障碍也加剧了这个问题，因为与关税相关的供应商变更通常需要重新认证设备，从而延缓了产品上市时间。企业正透过关键零件的双重采购、扩大国内同质化产品的生产以及加速研发经济高效材料来降低风险。

本研究报告是就地检验 ）最新系列报告的一部分，提供全球就地检验（POC​​T）行业的市场统计数据，包括市场规模、区域份额、竞争对手及其市场份额、详细的市场细分、市场趋势和商业机会，为您提供在即时检测（POC​​T）行业取得成功所需的全部数据。本市场研究报告对行业现状和未来发展趋势进行了详细分析，为您提供全面的市场概览。

远端医疗的日益普及预计将推动就地检验（POC​​T）市场的成长。远端医疗透过视讯通话、电话和安全即时通讯方式提供远距医疗服务，由于人们对便利、及时和非接触式医疗服务的需求不断增长，远距医疗正日益普及，而新冠疫情加速了这一趋势。 POCT与远端医疗相辅相成，能够快速且可靠地将诊断结果即时共用给远距医疗服务提供者。例如，根据Rock Health在2023年2月对8014名受访者进行的调查，55岁及以上人群中有76%使用过远端医疗，所有受访者中有80%至少使用过一次远端医疗，比2021年增长了8%。

POCT（即时检测）市场的企业正在利用智慧设备解决方案来简化工作流程、辅助决策并改善患者预后。例如，血糖管理解决方案能够即时监测和控製糖尿病患者的血糖值。 2022年1月，瑞士製药公司罗氏（F. Hoffmann-La Roche AG）推出了Cobas Pulse系统，这是一个将先进的POCT血糖监测与智慧型设备整合结合的互联平台。该系统能够自动将检测结果传输到医院的IT系统，并透过医疗保健应用程式支援临床决策，从而简化患者在家门口的诊断流程。

2024年8月，美国医疗检测公司Quest Diagnostics Inc.以10亿美元（约13.5亿加币）收购了LifeLabs LP。此次收购使Quest Diagnostics Inc.能够扩展其即时检测服务，并提升创新诊断解决方案的可近性。 LifeLabs LP是一家总部位于加拿大的即时检测服务提供者。

就地检验(POCT) 市场包括提供现场诊断检测、快速疾病检测、行动医疗筛检和患者自测支援等服务的营业单位所获得的收益。市场价值还包括服务提供者销售的或包含在其服务产品中的相关产品的价值。就地检验(POCT) 市场包括手持式糖化血红素 (HbA1c) 分析仪、手持式血液气体分析仪、C反应蛋白 (CRP)检测套组、多重呼吸道病原体检测套件和侧向流动尿液分析仪的销售。该市场的价值为“出厂价”，即产品製造商或创建者向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的产品价值。该市场的产品价值还包括产品创建者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球就地检验（POC​​T）：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 终端用户产业分析
  • 全球就地检验（POC​​T）市场：成长率分析
  • 全球就地检验（POC​​T）市场表现：规模与成长，2019-2024年
  • 全球就地检验（POC​​T）市场预测：规模与成长，2024-2029年，2034年
  • 全球就地检验（POC​​T）：潜在市场规模（TAM）

第六章 市场细分

  • 全球就地检验（POC​​T）市场按类型、性能和预测划分，2019-2024年、2024-2029年、2034年
  • 血糖值检测
  • 传染病检查
  • 心臟标记检测
  • 血液凝固检验
  • 妊娠和不孕症检查
  • 血气和电解质检查
  • 尿液检查
  • 其他的
  • 全球就地检验（POC​​T）市场按购买类型、性能和预测划分，2019-2024年、2024-2029年、2034年
  • 非处方药
  • 处方笺
  • 全球就地检验（POC​​T）市场：按技术、性能和预测划分，2019-2024年、2024-2029年、2034年
  • 免疫检测
  • 分子诊断
  • 微生物检测
  • 聚合酵素链锁反应（PCR）检测
  • 生物化学检验
  • 全球就地检验（POC​​T）市场按最终用户、效能和预测划分，2019-2024年、2024-2029年、2034年
  • 临床实验室
  • 门诊医疗机构及诊所
  • 药局
  • 零售诊所/电子商务平台
  • 医院
  • 加护治疗中心
  • 急诊中心
  • 居家医疗/自我检测
  • 其他的
  • 全球就地检验（POC​​T）市场：血糖值检测细分市场，按类型、性能和预测，2019-2024年、2024-2029年、2034年
  • 自测血糖仪
  • 连续血糖监测设备
  • 瞬感血糖监测装置
  • 全球就地检验（POC​​T）市场：传染病检查细分市场，按类型、性能和预测，2019-2024年、2024-2029年、2034年
  • 人类免疫力缺乏病毒（HIV）检测
  • 肝炎检测
  • 流感检测
  • 新冠病毒检测
  • 其他传染病检查
  • 全球就地检验（POC​​T）市场：心臟标记检测细分市场，按类型、性能和预测，2019-2024年、2024-2029年、2034年
  • 肌钙蛋白检测
  • 肌酸激酶MB（CK-MB）检测
  • 肌红蛋白检测
  • B型钠尿肽（BNP）检测
  • 全球就地检验（POC​​T）市场：血液凝固检验细分市场，按类型、性能和预测（2019-2024年、2024-2029年、2034年）
  • 凝血酶原时间（PT）检测
  • 活化部份凝血活酵素时间（aPTT）检测
  • 国际标准化比值（INR）检测
  • 全球就地检验（POC​​T）市场：妊娠和不孕症检测细分市场，按类型、性能和预测，2019-2024年、2024-2029年、2034年
  • 检测套组
  • 排卵检测套组
  • 生殖荷尔蒙检测
  • 全球就地检验（POC​​T）市场：血气和电解质检测细分市场，按类型、性能和预测，2019-2024年、2024-2029年、2034年
  • 动脉血气检测
  • 静脉血气检测
  • 电解质测试（钠、钾、氯）
  • 全球就地检验（POC​​T）市场：尿液检查细分市场，按类型、性能和预测，2019-2024年、2024-2029年、2034年
  • 尿液化学分析
  • 尿液显微镜分析
  • 尿液培养
  • 全球就地检验（POC​​T）市场：其他细分市场、按类型、性能和预测划分，2019-2024年、2024-2029年、2034年
  • 药物滥用检测
  • 过敏测试
  • 胆固醇检测
  • 甲状腺功能检查

第七章 区域和国家分析

  • 全球就地检验（POC​​T）市场：区域表现及预测，2019-2024年、2024-2029年及2034年
  • 全球就地检验（POC​​T）市场：国家/地区、绩效及预测，2019-2024年、2024-2029年、2034年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 就地检验（POC​​T）市场：竞争格局
  • 就地检验（POC​​T）市场：公司概况
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Siemens Healthineers AG
  • Becton Dickinson and Company
  • Zoetis Inc.
  • BioMerieux SA
  • QuidelOrtho Corporation
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • Nova Biomedical Corporation
  • LifeScan Inc.
  • Ascensia Diabetes Care Holdings AG
  • Trividia Health Inc.
  • Trinity Biotech Plc
  • SiPhox Inc.
  • Sinocare Inc.

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 就地检验2029：提供新机会的国家
  • 就地检验（POC​​T）市场2029：充满新机会的细分市场
  • 就地检验(POCT) 市场 2029 年：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r37862

Point-of-care testing (POCT) refers to diagnostic testing conducted at or near the site of patient care, providing immediate results and enabling faster clinical decision-making. Its purpose is to deliver quick and accurate diagnostic information directly at the point of care, facilitating timely treatment and improved patient outcomes.

The primary types of point-of-care testing (POCT) include blood glucose testing, infectious disease testing, cardiac marker testing, coagulation testing, pregnancy and fertility testing, blood gas or electrolyte testing, urinalysis testing, and others. Blood glucose testing involves measuring the amount of sugar (glucose) in a person's blood to monitor and manage related conditions. POCT products are available through various purchase modes, including over-the-counter and prescription-based products, and utilize technologies such as immunoassays, molecular diagnostics, microbial detection, polymerase chain reaction (PCR) testing, and biochemical testing. Key end users include clinical laboratories, ambulatory care facilities, physician offices, pharmacies, retail clinics, e-commerce platforms, hospitals, critical care centers, urgent care centers, home care and self-testing, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The point-of-care-testing (POCT) market research report is one of a series of new reports from The Business Research Company that provides point-of-care-testing (POCT) market statistics, including the point-of-care-testing (POCT) industry global market size, regional shares, competitors with the point-of-care-testing (POCT) market share, detailed point-of-care-testing (POCT) market segments, market trends, and opportunities, and any further data you may need to thrive in the point-of-care-testing (POCT) industry. This point-of-care-testing (POCT) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The point-of-care-testing (POCT) market size has grown rapidly in recent years. It will grow from $45.45 billion in 2024 to $50.79 billion in 2025 at a compound annual growth rate (CAGR) of 11.8%. The growth during the historical period can be attributed to a growing focus on personalized medicine, increasing investments in healthcare infrastructure, a rise in emergency care cases, expanded use of point-of-care molecular testing, and greater integration of AI in diagnostics.

The point-of-care-testing (POCT) market size is expected to see rapid growth in the next few years. It will grow to $78.19 billion in 2029 at a compound annual growth rate (CAGR) of 11.4%. The growth during the forecast period can be attributed to increasing demand for personalized medicine, expanding telehealth and remote monitoring trends, rising healthcare access in emerging markets, broader application in non-traditional settings, and growing adoption of wearable diagnostic devices. Key trends expected in the forecast period include advancements in multiplex testing platforms, development of portable molecular diagnostic devices, innovations in smartphone-based diagnostic tools, improvements in connectivity and data integration, and the emergence of AI-powered POCT solutions.

The increasing adoption of telemedicine is expected to drive growth in the point-of-care testing (POCT) market. Telemedicine delivering healthcare remotely via video calls, phone, or secure messaging has gained traction due to rising demand for convenient, timely, and contact-free care, a trend accelerated by the COVID-19 pandemic. POCT complements telemedicine by enabling rapid, reliable diagnostic results that can be shared instantly with remote healthcare providers. For example, a February 2023 survey by Rock Health of 8,014 respondents found that 76% of individuals over 55 had used telemedicine, and 80% of all participants had accessed care remotely at least once, up 8% from 2021.

Companies in the POCT market are leveraging smart device-enabled solutions to improve workflow efficiency, decision support, and patient outcomes in near-patient settings. Blood glucose management solutions, for instance, allow for real-time monitoring and control of blood sugar levels in patients with diabetes. In January 2022, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, launched the Cobas Pulse system, a connected platform combining advanced POCT blood glucose testing with smart device integration. The system enables automatic result transfer to hospital IT systems and supports clinical decision-making through healthcare apps, streamlining near-patient diagnostics.

In August 2024, Quest Diagnostics Inc., a US-based medical laboratory company, acquired LifeLabs LP for $1 billion (CAN $1.35 billion). This acquisition expands Quest Diagnostics' POCT offerings and strengthens access to innovative diagnostic solutions. LifeLabs LP is a Canada-based provider of point-of-care testing services.

Major players in the point-of-care-testing (POCT) market are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Zoetis Inc., BioMerieux SA, QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Nova Biomedical Corporation, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Trinity Biotech Plc, SiPhox Inc., and Sinocare Inc.

North America was the largest region in the point-of-care testing (POCT) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in point-of-care testing (POCT) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the point-of-care testing (POCT) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The point-of-care testing (POCT) market includes revenues earned by entities by providing services such as on-site diagnostic testing, rapid disease detection, mobile health screening, and patient self-testing support. The market value includes the value of related goods sold by the service provider or included within the service offering. The point-of-care testing (POCT) market includes sales of portable HbA1c analyzers, handheld blood gas analyzers, CRP (C-reactive protein) test kits, multiplex respiratory pathogen detection kits, and lateral flow urine analysis devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Point-Of-Care-Testing (POCT) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on point-of-care-testing (poct) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for point-of-care-testing (poct) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The point-of-care-testing (poct) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Blood Glucose Testing; Infectious Diseases Testing; Cardiac Markers Testing; Coagulation Testing; Pregnancy And Fertility Testing; Blood Gas Or Electrolytes Testing; Urinalysis Testing; Other Types
  • 2) By Mode Of Purchase: Over-The-Counter Products; Prescribed Based Products
  • 3) By Technology: Immunoassays; Molecular Diagnostics; Microbial Detection; Polymerase Chain Reaction (PCR) Testing; Biochemical Testing
  • 4) By End-User: Clinical Laboratories; Ambulatory Care Facilities And Physician Offices; Pharmacies; Retail Clinics And E-Comm Platforms; Hospitals; Critical Care Centres; Urgent Care Centres; Home Care And Self-Testing; Other End-Users
  • Subsegments:
  • 1) By Blood Glucose Testing: Self-Monitoring Blood Glucose Devices; Continuous Glucose Monitoring Devices; Flash Glucose Monitoring Devices
  • 2) By Infectious Diseases Testing: Human Immunodeficiency Virus (HIV) Testing; Hepatitis Testing; Influenza Testing; COVID-19 Testing; Other Infectious Diseases Testing
  • 3) By Cardiac Markers Testing: Troponin Testing; Creatine Kinase-MB (CK-MB) Testing; Myoglobin Testing; B-type Natriuretic Peptide (BNP) Testing
  • 4) By Coagulation Testing: Prothrombin Time (PT) Testing; Activated Partial Thromboplastin Time (aPTT) Testing; International Normalized Ratio (INR) Testing
  • 5) By Pregnancy And Fertility Testing: Pregnancy Test Kits; Ovulation Test Kits; Fertility Hormone Testing
  • 6) By Blood Gas Or Electrolytes Testing: Arterial Blood Gas Testing; Venous Blood Gas Testing; Electrolyte Testing
  • 7) By Urinalysis Testing: Urine Chemistry Analysis; Microscopic Urine Analysis; Urine Culture Testing
  • 8) By Other Types: Drug Abuse Testing; Allergy Testing; Cholesterol Testing; Thyroid Function Testing
  • Companies Mentioned: Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Becton Dickinson and Company; Zoetis Inc.; BioMerieux SA; QuidelOrtho Corporation; Sysmex Corporation; Bio-Rad Laboratories Inc.; QIAGEN NV; Nova Biomedical Corporation; LifeScan Inc.; Ascensia Diabetes Care Holdings AG; Trividia Health Inc.; Trinity Biotech Plc; SiPhox Inc.; Sinocare Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Point-Of-Care-Testing (POCT) Market Characteristics

3. Point-Of-Care-Testing (POCT) Market Trends And Strategies

4. Point-Of-Care-Testing (POCT) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Point-Of-Care-Testing (POCT) Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Point-Of-Care-Testing (POCT) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Point-Of-Care-Testing (POCT) Market Growth Rate Analysis
  • 5.4. Global Point-Of-Care-Testing (POCT) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Point-Of-Care-Testing (POCT) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Point-Of-Care-Testing (POCT) Total Addressable Market (TAM)

6. Point-Of-Care-Testing (POCT) Market Segmentation

  • 6.1. Global Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Glucose Testing
  • Infectious Diseases Testing
  • Cardiac Markers Testing
  • Coagulation Testing
  • Pregnancy And Fertility Testing
  • Blood Gas Or Electrolytes Testing
  • Urinalysis Testing
  • Other Types
  • 6.2. Global Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Over-The-Counter Products
  • Prescribed Based Products
  • 6.3. Global Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immunoassays
  • Molecular Diagnostics
  • Microbial Detection
  • Polymerase Chain Reaction (PCR) Testing
  • Biochemical Testing
  • 6.4. Global Point-Of-Care-Testing (POCT) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinical Laboratories
  • Ambulatory Care Facilities And Physician Offices
  • Pharmacies
  • Retail Clinics And E-Comm Platforms
  • Hospitals
  • Critical Care Centres
  • Urgent Care Centres
  • Home Care And Self-Testing
  • Other End-Users
  • 6.5. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Blood Glucose Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Self-Monitoring Blood Glucose Devices
  • Continuous Glucose Monitoring Devices
  • Flash Glucose Monitoring Devices
  • 6.6. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Infectious Diseases Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Human Immunodeficiency Virus (HIV) Testing
  • Hepatitis Testing
  • Influenza Testing
  • COVID-19 Testing
  • Other Infectious Diseases Testing
  • 6.7. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Cardiac Markers Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Troponin Testing
  • Creatine Kinase-MB (CK-MB) Testing
  • Myoglobin Testing
  • B-type Natriuretic Peptide (BNP) Testing
  • 6.8. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Coagulation Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Prothrombin Time (PT) Testing
  • Activated Partial Thromboplastin Time (aPTT) Testing
  • International Normalized Ratio (INR) Testing
  • 6.9. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Pregnancy And Fertility Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pregnancy Test Kits
  • Ovulation Test Kits
  • Fertility Hormone Testing
  • 6.10. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Blood Gas Or Electrolytes Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Arterial Blood Gas Testing
  • Venous Blood Gas Testing
  • Electrolyte Testing (Sodium, Potassium, Chloride)
  • 6.11. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Urinalysis Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Urine Chemistry Analysis
  • Microscopic Urine Analysis
  • Urine Culture Testing
  • 6.12. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Abuse Testing
  • Allergy Testing
  • Cholesterol Testing
  • Thyroid Function Testing

7. Point-Of-Care-Testing (POCT) Market Regional And Country Analysis

  • 7.1. Global Point-Of-Care-Testing (POCT) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Point-Of-Care-Testing (POCT) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Point-Of-Care-Testing (POCT) Market

  • 8.1. Asia-Pacific Point-Of-Care-Testing (POCT) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Point-Of-Care-Testing (POCT) Market

  • 9.1. China Point-Of-Care-Testing (POCT) Market Overview
  • 9.2. China Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Point-Of-Care-Testing (POCT) Market

  • 10.1. India Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Point-Of-Care-Testing (POCT) Market

  • 11.1. Japan Point-Of-Care-Testing (POCT) Market Overview
  • 11.2. Japan Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Point-Of-Care-Testing (POCT) Market

  • 12.1. Australia Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Point-Of-Care-Testing (POCT) Market

  • 13.1. Indonesia Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Point-Of-Care-Testing (POCT) Market

  • 14.1. South Korea Point-Of-Care-Testing (POCT) Market Overview
  • 14.2. South Korea Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Point-Of-Care-Testing (POCT) Market

  • 15.1. Western Europe Point-Of-Care-Testing (POCT) Market Overview
  • 15.2. Western Europe Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Point-Of-Care-Testing (POCT) Market

  • 16.1. UK Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Point-Of-Care-Testing (POCT) Market

  • 17.1. Germany Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Point-Of-Care-Testing (POCT) Market

  • 18.1. France Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Point-Of-Care-Testing (POCT) Market

  • 19.1. Italy Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Point-Of-Care-Testing (POCT) Market

  • 20.1. Spain Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Point-Of-Care-Testing (POCT) Market

  • 21.1. Eastern Europe Point-Of-Care-Testing (POCT) Market Overview
  • 21.2. Eastern Europe Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Point-Of-Care-Testing (POCT) Market

  • 22.1. Russia Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Point-Of-Care-Testing (POCT) Market

  • 23.1. North America Point-Of-Care-Testing (POCT) Market Overview
  • 23.2. North America Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Point-Of-Care-Testing (POCT) Market

  • 24.1. USA Point-Of-Care-Testing (POCT) Market Overview
  • 24.2. USA Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Point-Of-Care-Testing (POCT) Market

  • 25.1. Canada Point-Of-Care-Testing (POCT) Market Overview
  • 25.2. Canada Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Point-Of-Care-Testing (POCT) Market

  • 26.1. South America Point-Of-Care-Testing (POCT) Market Overview
  • 26.2. South America Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Point-Of-Care-Testing (POCT) Market

  • 27.1. Brazil Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Point-Of-Care-Testing (POCT) Market

  • 28.1. Middle East Point-Of-Care-Testing (POCT) Market Overview
  • 28.2. Middle East Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Point-Of-Care-Testing (POCT) Market

  • 29.1. Africa Point-Of-Care-Testing (POCT) Market Overview
  • 29.2. Africa Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Point-Of-Care-Testing (POCT) Market Competitive Landscape And Company Profiles

  • 30.1. Point-Of-Care-Testing (POCT) Market Competitive Landscape
  • 30.2. Point-Of-Care-Testing (POCT) Market Company Profiles
    • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Point-Of-Care-Testing (POCT) Market Other Major And Innovative Companies

  • 31.1. Siemens Healthineers AG
  • 31.2. Becton Dickinson and Company
  • 31.3. Zoetis Inc.
  • 31.4. BioMerieux SA
  • 31.5. QuidelOrtho Corporation
  • 31.6. Sysmex Corporation
  • 31.7. Bio-Rad Laboratories Inc.
  • 31.8. QIAGEN NV
  • 31.9. Nova Biomedical Corporation
  • 31.10. LifeScan Inc.
  • 31.11. Ascensia Diabetes Care Holdings AG
  • 31.12. Trividia Health Inc.
  • 31.13. Trinity Biotech Plc
  • 31.14. SiPhox Inc.
  • 31.15. Sinocare Inc.

32. Global Point-Of-Care-Testing (POCT) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Point-Of-Care-Testing (POCT) Market

34. Recent Developments In The Point-Of-Care-Testing (POCT) Market

35. Point-Of-Care-Testing (POCT) Market High Potential Countries, Segments and Strategies

  • 35.1 Point-Of-Care-Testing (POCT) Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Point-Of-Care-Testing (POCT) Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Point-Of-Care-Testing (POCT) Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer